urMut final evaluatio
Not Applicable
- Conditions
- F03Unspecified dementia
- Registration Number
- DRKS00013918
- Lead Sponsor
- Charité - Universitätsmedizin Berlin, Forschungsgruppe Geriatrie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Persons suffering from a clinically diagnosed dementia: aged 65 and older, written informed consent (participant or legal guardian); ambulant setting: living together with one or more relative.
caregiver/ relative: minimum part-time working (50%) in caregiving; ambulant setting: living together with study participant (person with dementia)
Exclusion Criteria
Persons with dementia: lack of ability to express themselves in language.
Cargiver/ relative: more than 4 weeks of absence during study phase.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Analysis of the human-machine-interaction of people with dementia and music therapists (user behavior, usability, acceptability) with a music system.<br><br>End of the intervention phase: <br>music therapists: <br>- self-developed questionnaire about user behavior <br>- usability (Normalization Process Theory, NOMAD) <br>- Acceptability (adapted from Music in Dementia Assessment Scale, MiDAS. <br>people with dementia (external assessment by relative or caregiver): <br>- self-developed questionnaire about user behavior <br>- Acceptability (adapted from Music in Dementia Assessment Scale, MiDAS) <br>- Usability (Usefulness, Satisfaction and Ease of use, USE; System Usability Scale, SUS) <br>- quality of life (Alzheimer's Disease Related Quality of Life, ADRQL) <br>- Depression (Cornell Depression Scale, CDS) <br>- Agitation (Cohen Mansfield Agitation Inventory, CMAI) <br>- Apathy (Apathy Evaluation Scale, AES).
- Secondary Outcome Measures
Name Time Method Efficay of a music system for people with dementia regarding 1. improvement of life quality 2. reduction of apathy and agitation episodes<br><br>